as 11-01-2024 4:00pm EST
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Upcoming Earnings Alert:
Get ready for potential market movements as Verona Pharma plc VRNA prepares to release earnings report on 04 Nov 2024.
Founded: | 2005 | Country: | United Kingdom |
Employees: | N/A | City: | LONDON |
Market Cap: | 2.2B | IPO Year: | 2017 |
Target Price: | $39.33 | AVG Volume (30 days): | 868.6K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.59 | EPS Growth: | N/A |
52 Week Low/High: | $11.39 - $35.62 | Next Earning Date: | 11-04-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | 1077.76% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ZACCARDELLI DAVID | VRNA | President and CEO | Oct 23 '24 | Sell | $4.38 | 144,816 | $633,895.84 | 14,736,536 | |
ZACCARDELLI DAVID | VRNA | President and CEO | Sep 11 '24 | Sell | $3.76 | 600,000 | $2,254,320.00 | 14,736,536 | |
EBSWORTH DAVID R | VRNA | Director | Aug 12 '24 | Buy | $2.87 | 36,000 | $103,320.00 | 880,643 | |
ZACCARDELLI DAVID | VRNA | President and CEO | Aug 12 '24 | Sell | $3.19 | 400,000 | $1,280,688.98 | 14,736,536 | |
Hahn Mark W | VRNA | Chief Financial Officer | Aug 12 '24 | Sell | $3.19 | 400,000 | $1,280,548.40 | 14,939,688 |
VRNA Breaking Stock News: Dive into VRNA Ticker-Specific Updates for Smart Investing
GuruFocus.com
a day ago
Zacks
8 days ago
Zacks
8 days ago
Zacks
9 days ago
MT Newswires
10 days ago
MT Newswires
10 days ago
GlobeNewswire
12 days ago
Zacks
22 days ago
The information presented on this page, "VRNA Verona Pharma plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.